Variant report

Variant	esv14331
Chromosome Location	chr17:20459147-20491117
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:73)
CpG islands
(count:672)
Chromatin interactive
region (count:1)
LncRNA
region (count:14)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:73 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CEBPB	chr17:20469051-20469059	Hela-S3	cervix:	n/a	n/a
2	CEBPB	chr17:20468918-20469141	HepG2	liver:	n/a	chr17:20469062-20469073
3	CEBPB	chr17:20474419-20474705	HepG2	liver:	n/a	chr17:20474573-20474584
4	CEBPB	chr17:20474531-20474698	IMR90	lung:	n/a	chr17:20474573-20474584
5	CEBPB	chr17:20469063-20469069	K562	blood:	n/a	n/a
6	CEBPB	chr17:20474412-20474706	A549	lung:	n/a	chr17:20474573-20474584
7	CEBPB	chr17:20474504-20474704	Hela-S3	cervix:	n/a	chr17:20474573-20474584
8	CTCF	chr17:20461607-20461627	GM10248	blood:	n/a	n/a
9	CTCF	chr17:20473805-20473839	GM13976	blood:	n/a	n/a
10	CTCF	chr17:20487357-20487462	K562	blood:	n/a	n/a
11	CTCF	chr17:20487351-20487529	Fibrobl	skin:	n/a	n/a
12	CTCF	chr17:20487387-20487440	LNCaP	prostate:	n/a	n/a
13	CTCF	chr17:20467202-20467272	Kidney_OC	kidney:	n/a	n/a
14	CTCF	chr17:20487326-20487535	GM12878	blood:	n/a	n/a
15	CTCF	chr17:20487336-20487504	ProgFib	skin:	n/a	n/a
16	CTCF	chr17:20487360-20487490	HepG2	liver:	n/a	n/a
17	CTCF	chr17:20487369-20487493	GM19238	blood:	n/a	n/a
18	CTCF	chr17:20487312-20487526	GM12891	blood:	n/a	n/a
19	CTCF	chr17:20487329-20487520	Hela-S3	cervix:	n/a	n/a
20	CTCF	chr17:20487314-20487552	GM12892	blood:	n/a	n/a
21	CTCF	chr17:20487327-20487528	A549	lung:	n/a	n/a
22	CTCF	chr17:20487298-20487527	H1-hESC	embryonic stem cell:	n/a	n/a
23	CTCF	chr17:20487308-20487542	Gliobla	brain:	n/a	n/a
24	CTCF	chr17:20487480-20487630	HEK293	kidney:	n/a	n/a
25	CTCF	chr17:20487302-20487541	MCF-7	breast:	n/a	n/a
26	CTCF	chr17:20472223-20472240	GM10266	blood:	n/a	n/a
27	CTCF	chr17:20487301-20487561	MCF-7	breast:	n/a	n/a
28	CTCF	chr17:20487440-20487590	SAEC	small airway:	n/a	n/a
29	CTCF	chr17:20487480-20487630	GM12873	blood:	n/a	n/a
30	CTCF	chr17:20487440-20487590	SK-N-SH_RA	brain:	n/a	n/a
31	CTCF	chr17:20477727-20477839	GM20000	blood:	n/a	n/a
32	CTCF	chr17:20487353-20487496	GM19240	blood:	n/a	n/a
33	CTCF	chr17:20487375-20487526	Pancreas_OC	pancreas:	n/a	n/a
34	CTCF	chr17:20487262-20487496	A549	lung:	n/a	n/a
35	CTCF	chr17:20466716-20466765	GM10266	blood:	n/a	n/a
36	CTCF	chr17:20487394-20487465	HUVEC	blood vessel:	n/a	n/a
37	CTCF	chr17:20461592-20461601	GM10248	blood:	n/a	n/a
38	CTCF	chr17:20487287-20487548	MCF-7	breast:	n/a	n/a
39	CTCF	chr17:20487329-20487537	NHEK	skin:	n/a	n/a
40	CTCF	chr17:20487305-20487537	MCF-7	breast:	n/a	n/a
41	CTCF	chr17:20487356-20487475	GM19239	blood:	n/a	n/a
42	CTCF	chr17:20487293-20487541	MCF-7	breast:	n/a	n/a
43	CTCF	chr17:20487371-20487483	Medullo	brain:	n/a	n/a
44	EP300	chr17:20487434-20488099	SK-N-SH	brain:	n/a	n/a
45	FOXA2	chr17:20476612-20477221	A549	lung:	n/a	n/a
46	FOXA2	chr17:20460992-20461286	A549	lung:	n/a	n/a
47	GABPA	chr17:20475076-20475338	Hela-S3	cervix:	n/a	n/a
48	GATA2	chr17:20461039-20461297	K562	blood:	n/a	n/a
49	JUND	chr17:20463805-20463978	K562	blood:	n/a	chr17:20463845-20463853 chr17:20463844-20463854 chr17:20463844-20463854 chr17:20463845-20463852 chr17:20463845-20463853 chr17:20463844-20463854 chr17:20463844-20463854
50	MAX	chr17:20465764-20465921	NB4	blood:	n/a	chr17:20465905-20465915

(count:672 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr17:20464366-20464416	ECC-1	luminal epithelium:	n/a
2	chr17:20464366-20464416	ECC-1	luminal epithelium:	n/a
3	chr17:20481830-20481880	HNPCEpiC	eye:	n/a
4	chr17:20480574-20480624	NB4	blood:	n/a
5	chr17:20491042-20491092	HepG2	liver:	n/a
6	chr17:20464366-20464416	NHDF-neo	bronchial:	n/a
7	chr17:20467831-20467881	MCF10A-Er-Src	breast:	n/a
8	chr17:20467917-20467967	AoSMC	blood vessel:	n/a
9	chr17:20467831-20467881	BE2_C	brain:	n/a
10	chr17:20460588-20460638	AG04449	skin:	fetal
11	chr17:20460588-20460638	AoSMC	blood vessel:	n/a
12	chr17:20464366-20464416	HIPEpiC	eye:	n/a
13	chr17:20460627-20460677	Hela-S3	cervix:	n/a
14	chr17:20464366-20464416	LNCaP	prostate:	n/a
15	chr17:20481830-20481880	IMR90	lung:	fetal
16	chr17:20465437-20465487	HL-60	blood:	n/a
17	chr17:20491042-20491092	GM06990	blood:	n/a
18	chr17:20467965-20468015	H1-hESC	embryonic stem cell:	embryo
19	chr17:20460627-20460677	AG10803	skin:	n/a
20	chr17:20489071-20489121	GM06990	blood:	n/a
21	chr17:20460588-20460638	HRCEpiC	kidney:	n/a
22	chr17:20460588-20460638	RPTEC	kidney:	n/a
23	chr17:20491042-20491092	NB4	blood:	n/a
24	chr17:20481830-20481880	BE2_C	brain:	n/a
25	chr17:20491042-20491092	SK-N-SH_RA	brain:	n/a
26	chr17:20460627-20460677	SKMC	muscle:	n/a
27	chr17:20489071-20489121	HPAEpiC	pulmonary alveolar:	n/a
28	chr17:20467831-20467881	NB4	blood:	n/a
29	chr17:20491042-20491092	HIPEpiC	eye:	n/a
30	chr17:20467965-20468015	HMEC	breast:	n/a
31	chr17:20481830-20481880	A549	lung:	n/a
32	chr17:20480574-20480624	GM12878	blood:	n/a
33	chr17:20467917-20467967	SK-N-SH	brain:	n/a
34	chr17:20464366-20464416	AG09309	skin:	n/a
35	chr17:20467831-20467881	PrEC	prostate:	n/a
36	chr17:20460588-20460638	HIPEpiC	eye:	n/a
37	chr17:20467965-20468015	AG04449	skin:	fetal
38	chr17:20467965-20468015	SAEC	small airway:	n/a
39	chr17:20467831-20467881	HCF	heart:	n/a
40	chr17:20491042-20491092	HEEpiC	esophagus:	n/a
41	chr17:20480574-20480624	HepG2	liver:	n/a
42	chr17:20491042-20491092	NHDF-neo	bronchial:	n/a
43	chr17:20467831-20467881	HNPCEpiC	eye:	n/a
44	chr17:20467831-20467881	HepG2	liver:	n/a
45	chr17:20460588-20460638	AG10803	skin:	n/a
46	chr17:20464366-20464416	HCPEpiC	choroid plexus:	n/a
47	chr17:20481830-20481880	SK-N-SH	brain:	n/a
48	chr17:20480574-20480624	U87	brain:	n/a
49	chr17:20467917-20467967	HUVEC	blood vessel:	n/a
50	chr17:20460627-20460677	A549	lung:	n/a

(count:1 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr17:18289123..18291183-chr17:20462480..20465308,2	MCF-7	breast:

(count:14 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-LGALS9B-2	chr17:20479798-20480107	XLOC_012419
2	lnc-LGALS9B-2	chr17:20478827-20479172	XLOC_012419
3	lnc-LGALS9B-2	chr17:20479866-20480107	XLOC_012419
4	lnc-LGALS9B-2	chr17:20479798-20480107	XLOC_012419
5	lnc-LGALS9B-13	chr17:20462661-20462723	NONHSAT146793
6	lnc-LGALS9B-2	chr17:20479980-20480210	ENSG00000264422.1
7	lnc-LGALS9B-2	chr17:20478895-20479172	XLOC_012419
8	lnc-LGALS9B-13	chr17:20459470-20459532	NONHSAT146793
9	lnc-LGALS9B-2	chr17:20478895-20479010	XLOC_012419
10	lnc-LGALS9B-2	chr17:20481940-20482234	XLOC_012419
11	lnc-LGALS9B-2	chr17:20481940-20482061	ENSG00000264422.1
12	lnc-LGALS9B-2	chr17:20481940-20482234	XLOC_012419
13	lnc-LGALS9B-2	chr17:20481940-20482149	XLOC_012419
14	lnc-LGALS9B-2	chr17:20479798-20480255	XLOC_012419

No data

Variant related genes	Relation type
ENSG00000263946	TF binding region
COTL1P2	TF binding region
MEIS3P2	TF binding region
ENSG00000264422	TF binding region
TBC1D3P3	TF binding region
CDRT15L2	TF binding region
ENSG00000263946	CpG island
COTL1P2	CpG island
MEIS3P2	CpG island
ENSG00000264422	CpG island
TBC1D3P3	CpG island
CDRT15L2	CpG island
ENSG00000214860	chromatin interactions
VPS4B	miRNA target sites
RNF125	miRNA target sites
GTF3C4	miRNA target sites

Extended variants
information (count: 1060 )
Associated
traits (count: 150 )

Variant overlapped rSNPs/rCNVs (count:1060 , 50 per page) page: 1 2 3 4 5 6 7 ... 22

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs7215911	chr17:20459155-20459156	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
2	rs1619339	chr17:20459190-20459191	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs146401692	chr17:20459208-20459209	Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs552151104	chr17:20459212-20459213	Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs189601718	chr17:20459216-20459217	Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs538297308	chr17:20459235-20459236	Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs550024002	chr17:20459236-20459237	Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs181862947	chr17:20459238-20459239	Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs2955840	chr17:20459244-20459245	Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs369711610	chr17:20459266-20459267	Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs11657407	chr17:20459319-20459320	Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs75488724	chr17:20459328-20459329	Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs114002028	chr17:20459338-20459339	Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs568268300	chr17:20459340-20459341	Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs67501675	chr17:20459341-20459342	Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs57597909	chr17:20459343-20459344	Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs58640533	chr17:20459354-20459355	Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs540138109	chr17:20459358-20459359	Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs574714150	chr17:20459405-20459406	Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs201115001	chr17:20459413-20459414	Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs558486446	chr17:20459429-20459430	Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs377534181	chr17:20459447-20459448	Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs576777245	chr17:20459451-20459452	Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs113399845	chr17:20459461-20459462	Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs112800985	chr17:20459471-20459472	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
26	rs113624258	chr17:20459506-20459507	Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
27	rs373919855	chr17:20459581-20459582	Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs184799780	chr17:20459586-20459587	Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs57570943	chr17:20459595-20459596	Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs116884879	chr17:20460261-20460262	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs181506559	chr17:20460264-20460265	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs201302813	chr17:20460282-20460283	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs138711766	chr17:20460285-20460286	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs553540280	chr17:20460311-20460312	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs368544320	chr17:20460326-20460327	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs571943294	chr17:20460339-20460340	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs546055105	chr17:20460361-20460362	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs143015590	chr17:20460366-20460367	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs11870436	chr17:20460417-20460418	Inactive region	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs543409104	chr17:20460420-20460421	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs562113905	chr17:20460433-20460434	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs529399585	chr17:20460466-20460467	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs547947899	chr17:20460469-20460470	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs186579199	chr17:20460512-20460513	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs533336999	chr17:20460541-20460542	Inactive region	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs11870625	chr17:20460606-20460607	Inactive region	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs570214035	chr17:20460607-20460608	Inactive region	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
48	rs537752018	chr17:20460613-20460614	Inactive region	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
49	rs572945230	chr17:20460617-20460618	Inactive region	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
50	rs538953945	chr17:20460628-20460629	Inactive region	CpG island	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:150)

Disease	PMID	Source
Wilms tumour	21544195	CNVD
Esophageal adenocarcinoma	18519675	CNVD
lymphocytic leukemia	21291569	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Chordoma	21602918	CNVD
Miller-Dieker syndrome	22283845	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Cancer	22429812	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Ewing''s sarcoma	21437220	CNVD
Follicular lymphoma	19010834	CNVD
Colorectal cancer	20709793	CNVD
Acute myeloid leukemia	16864856	CNVD
Endometrial cancer	22040021	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Breast cancer	22028636	CNVD
Breast cancer	20837533	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
colon cancer	17210682	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Basal cell lymphoma	17053054	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Cancer	16751803	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Chronic lymphocytic leukemia	17971485	CNVD
Basal cell lymphoma	17170743	CNVD
Breast cancer	16461572	CNVD
Colorectal cancer	16272173	CNVD
Follicular lymphoma	17170743	CNVD
Human rectal carcinomas	16397240	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	17133270	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Moyamoya disease	22323933	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	20729466	CNVD
Acute promyelocytic leukemia	19109227	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute myeloid leukemia	21251322	CNVD
Myelodysplastic syndrome	21251322	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20724749	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
Colorectal cancer	21645411	CNVD
HIV/AIDS	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
HIV/AIDS	17953491	CNVD
HIV/AIDS	20877625	CNVD
Immune disease	21076436	CNVD
Rheumatoid arthritis	17953491	CNVD
Type 1 diabetes	17953491	CNVD
HIV/AIDS	15637236	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Ovarian cancer	21781307	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Neurofibromatosis	18196300	CNVD
Breast cancer	17001317	CNVD
Rhabdomyosarcoma	16790082	CNVD
Charcot-marie-tooth disease	16463004	CNVD
Osteosarcoma	22292074	CNVD
Breast cancer	17603634	CNVD
Charcot	16760730	CNVD
Mental retardation	17901693	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
ovarian endometriomas	16273235	CNVD
Smith-Magenis syndrome	18923513	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16272173	CNVD
Austim spectrum disorder	21302340	CNVD
Autism	22492990	CNVD
Congenital abnormalities	21549014	CNVD
Developmental delay	18414209	CNVD
Developmental delay	21549014	CNVD
Epilepsy	20970697	CNVD
Mental retardation	18414209	CNVD
Mental retardation	21549014	CNVD
Smith-Magenis syndrome	21981782	CNVD
Smith-Magenis syndrome	20188345	CNVD
Smith-Magenis syndrome	16775514	CNVD
Smith-Magenis syndrome	22585170	CNVD
Smith-Magenis syndrome	22241247	CNVD
Autism	20970697	CNVD
Mental retardation	19951919	CNVD
Potocki-Lupski syndrome	21271655	CNVD
Potocki-lupski syndrome	17357070	CNVD
Potocki-lupski syndrome	20110824	CNVD
Potocki-lupski syndrome	18923514	CNVD
Potocki-lupski syndrome	22241247	CNVD
Potocki-lupski syndrome	20188345	CNVD
Schizophrenia	21399695	CNVD
Mental retardation	16773131	CNVD
Adenocarcinoma	19607727	CNVD
Squamous cell cancer	19607727	CNVD
Non-small cell lung cancer	21829676	CNVD
Glioblastoma multiforme	17002787	CNVD
Charcot-marie-tooth disease	22470819	CNVD
Neurofibromatosis	22470819	CNVD
Neuropathy	22470819	CNVD
Smith-Magenis syndrome	18301319	CNVD
Smith-Magenis syndrome	17357070	CNVD
Smith-Magenis syndrome	18469339	CNVD
Smith-Magenis syndrome	22241097	CNVD
Smith-Magenis syndrome	22470819	CNVD
Tourette syndrome	18923514	CNVD
Type 1 diabetes	22470819	CNVD
Potocki-lupski syndrome	18469339	CNVD
Follicular lymphoma	20505157	CNVD
T-cell lymphomas	19863542	CNVD
Neuropathy	17597781	CNVD
Hepatocellular carcinoma	16750200	CNVD
Neurodevelopmental disorder	17015230	CNVD
Smith-Magenis syndrome	17597781	CNVD
Potocki-lupski syndrome	18059269	CNVD
Potocki-lupski syndrome	17597781	CNVD
Mental retardation	17847001	CNVD
Multiple myeloma	16616336	CNVD
Breast cancer	20409316	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Medulloblastoma	16783165	CNVD
Breast cancer	21509527	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:21 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:20458600-20459200	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
2	chr17:20458600-20459400	Enhancers	Primary B cells from peripheral blood	blood
3	chr17:20458600-20459400	Enhancers	Primary hematopoietic stem cells short term culture	blood
4	chr17:20458600-20459600	Enhancers	Primary monocytes fromperipheralblood	blood
5	chr17:20459000-20459200	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
6	chr17:20459000-20459400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
7	chr17:20459000-20459400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
8	chr17:20467200-20472400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
9	chr17:20467800-20468000	ZNF genes & repeats	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
10	chr17:20468000-20472000	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
11	chr17:20470600-20471200	Enhancers	Primary hematopoietic stem cells short term culture	blood
12	chr17:20470600-20471400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
13	chr17:20470800-20471400	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
14	chr17:20471400-20471800	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
15	chr17:20471800-20472200	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
16	chr17:20472000-20472200	Enhancers	Fetal Muscle Leg	muscle
17	chr17:20472000-20472400	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
18	chr17:20472400-20472800	ZNF genes & repeats	iPS DF 19.11 Cell Line	embryonic stem cell
19	chr17:20472800-20492200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
20	chr17:20484600-20484800	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
21	chr17:20484800-20492200	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links